LGND - Ligand Pharmaceuticals Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$291.00
DETAILS
HIGH:
$332.00
LOW:
$252.00
MEDIAN:
$289.00
CONSENSUS:
$291.00
DOWNSIDE:
9.80%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 4,172 | $832,940 | 0.0% | -5,174 | DECREASED |
| Cooperman | 2,200 | $439,230 | 0.0% | -5,400 | DECREASED |
| Dalio | 0 | $0 | -- | -4,207 | SOLD |
| Wood | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-30 | Reardon Andrew | officer: CLO & Secretary | J-Other | 132 | $160.71 | $21K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,081 | $312.28 | $338K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 700 | $313.46 | $219K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 396 | $308.99 | $122K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 104 | $310.20 | $32K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 900 | $315.78 | $284K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 600 | $317.15 | $190K |
| 2026-06-30 | Davis Todd C | director, officer: Chief Executive Officer | J-Other | 132 | $160.71 | $21K |
| 2026-06-30 | Espinoza Octavio | officer: Chief Financial Officer | J-Other | 17 | $160.71 | $3K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,119 | $311.72 | $349K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | M-Exempt | 5,000 | $52.27 | $261K |
| 2026-07-01 | Reardon Andrew | officer: CLO & Secretary | SELL | 100 | $314.58 | $31K |
| 2026-06-16 | Sabba Stephen L | director | M-Exempt | 2,145 | $66.13 | $142K |
| 2026-06-16 | Sabba Stephen L | director | SELL | 2,145 | $254.00 | $545K |
| 2026-06-12 | Haas Jason | director | SELL | 3,000 | $255.01 | $765K |
| 2026-06-12 | Haas Jason | director | SELL | 3,461 | $256.08 | $886K |
| 2026-06-12 | Haas Jason | director | M-Exempt | 1,000 | $51.56 | $52K |
| 2026-06-12 | Haas Jason | director | M-Exempt | 3,000 | $51.56 | $155K |
| 2026-06-11 | Aryeh Jason | director | SELL | 4,500 | $250.00 | $1.1M |
| 2026-06-10 | LAMATTINA JOHN L | director | SELL | 697 | $249.53 | $174K |
| 2026-06-10 | LAMATTINA JOHN L | director | SELL | 3,405 | $251.62 | $857K |
| 2026-06-10 | Aryeh Jason | director | SELL | 500 | $250.00 | $125K |
| 2026-06-10 | LAMATTINA JOHN L | director | SELL | 257 | $247.22 | $64K |
| 2026-06-05 | Aryeh Jason | director | A-Award | 836 | -- | -- |
| 2026-06-05 | Aryeh Jason | director | A-Award | 2,938 | $237.00 | $696K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-06-09 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |